Details of the Drug Formulations

General Information of Drug (ID: DMWE60C)

• Drug Name: Rufinamide Drug Info
• Synonyms: 106308-44-5; Inovelon; Banzel; 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide; CGP-33101; Cgp 33101; Xilep; 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide; RUF-331; UNII-WFW942PR79; RUF 331; 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide; WFW942PR79; C10H8F2N4O; E 2080; POGQSBRIGCQNEG-UHFFFAOYSA-N; 1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]-; NCGC00165883-02; E2080; DSSTox_CID_26506; DSSTox_RID_81675; DSSTox_GSID_46506; Banzel; Banzel, Rufinamide; E-2080; SYN-111; Rufinamide (USAN/INN); Inovelon/Banzel

Indication

Disease Entry	ICD 11	Status	REF
Epilepsy	8A60-8A68	Approved (orphan drug)	[1]
Pediatric lennox-gastaut syndrome	8A62.1	Approved	[2]
Seizure disorder	8A6Z	Approved	[1]

• Cross-matching ID:
  PubChem CID: 129228
  ChEBI ID: CHEBI:134966
  CAS Number: 106308-44-5
  TTD ID: D0MD2L
  INTEDE ID: DR1450
  ACDINA ID: D00610

Full List of Drug Formulations Containing This Drug

Rufinamide 200 mg tablet

Company	Formulation ID	FDA Description
Eisai	F19705	Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, corn

Rufinamide 400 mg tablet

Company	Formulation ID	FDA Description
Eisai	F19706	Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, corn

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7470).
• [2] Clinical pipeline report, company report or official report of Eisai.